Cargando…
ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis
Contribution of integrin superfamily genes to treatment resistance remains uncertain. Genome patterns of thirty integrin superfamily genes were analyzed of using bulk and single-cell RNA sequencing, mutation, copy number, methylation, clinical information, immune cell infiltration, and drug sensitiv...
Autores principales: | Zheng, Xiaohao, Du, Yongxing, Liu, Mingyang, Wang, Chengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239741/ https://www.ncbi.nlm.nih.gov/pubmed/37270717 http://dx.doi.org/10.1007/s10142-023-01122-z |
Ejemplares similares
-
Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer
por: Duan, Yunjie, et al.
Publicado: (2022) -
Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022) -
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
por: Kuninty, Praneeth R., et al.
Publicado: (2019) -
Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022) -
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)